We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KEN:NYSEKenon Holdings Ltd. Analysis

Data as of 2026-04-12 - not real-time

$88.17

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kenon Holdings is trading near its 52‑week high at $88.17, comfortably above the 20‑day SMA of $83.36 and the 50‑day SMA of $80.86, indicating strong short‑term price momentum. Technical gauges reinforce this bias: the RSI sits at 62.4, the MACD histogram is positive and the signal is bullish, while volume is on an increasing trend. However, valuation metrics are starkly out of line – the trailing P/E of 69.4 dwarfs the industry average of 23, and a discounted cash‑flow model caps fair value at roughly $19, suggesting the stock is severely overvalued. The dividend yield of 4.37% looks attractive, but a payout ratio exceeding 300% and a forward P/E of –66.8 raise serious doubts about sustainability. Fundamentally, the company posted robust revenue growth of 43% and holds ample cash ($1.59 B) against $1.78 B of debt, yet operating margins are thin (9.4%) and free cash flow is modest at $32 M, indicating limited cushion for future payouts.
The risk profile reflects high short‑term volatility (45% 30‑day) but a relatively low beta of 0.85, pointing to market‑wide swings rather than company‑specific moves. Geographic exposure to Israel and the United States adds medium geopolitical risk, while regulatory risk in the utilities sector remains medium to high. Given the extreme overvaluation, questionable dividend sustainability, and the potential for a price correction toward DCF levels, investors should approach KEN with caution despite its bullish technical backdrop.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (price above SMAs, positive MACD)
  • Severe valuation gap (price vs DCF fair value)
  • Dividend payout ratio far above earnings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and solid cash reserves
  • Thin operating margins and modest free cash flow
  • Elevated debt‑to‑equity ratio (≈56%)

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental overvaluation (P/E 69 vs industry 23, DCF $19)
  • Unsustainable dividend policy
  • Potential macro‑geopolitical and regulatory headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth43.10%
Profit Margin7.60%
P/E Ratio69.4
ROE5.07%
ROA0.81%
Debt/Equity55.87
P/B Ratio2.7
Op. Cash Flow$283.8M
Free Cash Flow$32.0M
Industry P/E23.0

Technical Analysis

TrendBullish
RSI62.4
Support$77.61
Resistance$89.89
MA 20$83.36
MA 50$80.86
MA 200$59.54
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09

Valuation

Fair Value$19.14
GradeOvervalued
TypeGrowth
Dividend Yield4.37%

Risk Assessment

Beta0.85
Volatility45.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.